Robert Michel
Until Robert L. Michel came along and founded The Dark Intelligence Group (DIG) two decades ago, the clinical laboratory industry and the anatomic pathology profession lacked a trustworthy source for information about the management and operations of medical laboratories. From its inception in 1995, The Dark Report quickly became the “go to” source of industry intelligence, innovations in lab management, and strategic market analysis.
This excellence in reporting has earned recognition from his peers. For example, twice Michel and The Dark Report have won national awards for best investigative reporting by the Specialty Information Publishers Association. In 2005, the award was for Michel’s coverage about how the anatomic pathology condominium laboratories (pod labs) operated by urologists and gastroenterologists came to be, who operated them, and how these owners marketed the AP condo labs to other physician groups. In 2009, Michel’s award for best investigative reporting resulted from his published interviews with Quest Diagnostics Incorporated when the company admitted that, for a period of 18 months, it had been reported inaccurate Vitamin 25(OH) D results because of problems with its laboratory-developed test methodology. The Dark Report’s story was picked up by The New York Times and was in the national news cycle for several days.
In his role as Editor-in-Chief, Michel brought unique capabilities to DIG and The Dark Report. His management training and diverse business experience—along with his skills as a concise writer and analyst—proved to be a winning combination for readers of The Dark Report. For that reason, Michel’s story has many intriguing elements.
Immediately prior to founding DIG, he had served in several executive positions for Nichols Institute based in Portland, Oregon, and San Juan Capistrano, California. This was during the time that Nichols Institute was an independent public lab company with annual revenues of about $280 million (prior to its acquisition by MetPath, Inc., now Quest Diagnostics Incorporated). He traveled extensively to many of the clinical lab business units owned by Nichols Institute in different regions of the United States and played a role in formulating effective market strategies in response to the emergence of closed-panel HMOs, capitated pricing, and full-risk managed care contracts, among other successful management initiatives.
Prior to his service at Nichols Institute, Michel served at three different Fortune 100 companies. These were Procter & Gamble, Centex Corporation, and Financial Corp. of America. Each was an opportunity to master new management techniques and apply them in different industries. Between these positions, he gained experience as an entrepreneur, having founded a real estate development firm and a general contracting company in the Southeastern United States.
Robert Michel earned a Bachelor of Arts degree in Economics at the University of California, Los Angeles, where he played rugby, a sport he participated in for another 22 years. He is a native of California and grew up in Santa Ana.
Articles by Robert Michel
New Instrument Targets Cervical Cancer Detection
From the Volume XIII No. 1 – January 16, 2006 Issue
CEO SUMMARY: Guided Therapeutics, Inc. of Norcross, Georgia is working to develop proprietary technology into an improved method for detecting cervical cancer. It wants to give ob-gyns and other physicians an instrument system that can be used in the office to provide real-time results to…
January 16, 2006 “Intelligence: Late Breaking Lab News”
From the Volume XIII No. 1 – January 16, 2006 Issue
In recent months, the buzz around the lab industry in Southern California has been that Healthline Clinical Laboratories, Inc. is up for sale. THE DARK REPORT believes news of a sales agreement is imminent. The new buyer is likely to be a pair of looking-for-work lab executives in th…
Helping Labs Get Ahead Of the CDHP Tsunami
From the Volume XII No. 18 – December 26, 2005 Issue
THIS IS THE THIRD WHITE PAPER published by THE DARK REPORT in the past 10 years. We think you will find it the single most important intelligence briefing we’ve produced. That’s because of two reasons. First, the American healthcare system is in the earliest stages of total revolution. Like ever…
Consumer-Directed Health Plans To Be Healthcare’s Next Wave
From the Volume XII No. 18 – December 26, 2005 Issue
“There is an opportunity for laboratories to put strategies in place to benefit from the changes triggered by wider use of CDHPs.” —Paul Mango CEO SUMMARY: It is widely known that growing numbers of employers are turning to consumer-directed…
Picking Top Ten Stories Of 2005 for Lab Industry
From the Volume XII No. 17 – December 5, 2005 Issue
CEO SUMMARY: THE DARK REPORT offers its pic…
Middleware Provides Opportunity For Labs to Gain New Functions
From the Volume XII No. 17 – December 5, 2005 Issue
“Even as more laboratories begin to use middleware, the number of functions and uses for middleware continues to increase —Gregory R Vail, CEO, Data Innovations, Inc. CEO SUMMARY: Middleware is attracting attention throughout the laboratory ind…
“December 5, 2005 Intelligence: Late Breaking Lab News”
From the Volume XII No. 17 – December 5, 2005 Issue
On November 9, Luminex Corporation was awarded the “2005 Clinical Diagnostics Technology of the Year” Award from Frost & Sullivan. The award recognizes “clinical diagnostics technology that shows the potential to become an industry standard, achieve a high …
Spectrum Lab Network Is Sold to Equity Investor
From the Volume XII No. 16 – November 14, 2005 Issue
CEO SUMMARY: Timing of the sale of Spectrum Laboratory Network to Apax Partners, L.P. was unexpected, but it’s been known for some time that the fast-growing regional laboratory was entertaining purchase offers. Under new ownership and with ready access to ample capital, Spectrum is optimis…
Private Equity Firms: Ready to Buy More Labs?
From the Volume XII No. 16 – November 14, 2005 Issue
CEO SUMMARY: Times are good in the laboratory industry. At least that’s the opinion of a growing number of professional investors. They are searching throughout the country for laboratories to acquire. They are motivated by the consistent financial performance of many lab companies, bot…
Congressional Bill Introduced On Cytology Proficiency Testing
From the Volume XII No. 16 – November 14, 2005 Issue
THERE’S A NEW CHALLENGE to the near-monopoly on cytology proficiency testing held by Midwest Institute of Medical Education(MIME) of Indianapolis, Indiana. Last Friday, the College of American Pathologists (CAP) announced a new bill in the House of Representatives…
CURRENT ISSUE

Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized